Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Schizophrenia

  Free Subscription


Articles published in Mol Psychiatry

Retrieve available abstracts of 116 articles:
HTML format
Text format



Single Articles


    February 2020
  1. ANDREOU C, Borgwardt S
    Structural and functional imaging markers for susceptibility to psychosis.
    Mol Psychiatry. 2020 Feb 17. pii: 10.1038/s41380-020-0679.
    PubMed     Text format     Abstract available


  2. MA L, Shcherbina A, Chetty S
    Variations and expression features of CYP2D6 contribute to schizophrenia risk.
    Mol Psychiatry. 2020 Feb 11. pii: 10.1038/s41380-020-0675.
    PubMed     Text format     Abstract available


  3. NI C, Jiang W, Wang Z, Wang Z, et al
    LncRNA-AC006129.1 reactivates a SOCS3-mediated anti-inflammatory response through DNA methylation-mediated CIC downregulation in schizophrenia.
    Mol Psychiatry. 2020 Feb 3. pii: 10.1038/s41380-020-0662.
    PubMed     Text format     Abstract available


  4. CLEYNEN I, Engchuan W, Hestand MS, Heung T, et al
    Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.
    Mol Psychiatry. 2020 Feb 3. pii: 10.1038/s41380-020-0654.
    PubMed     Text format     Abstract available


    January 2020
  5. SMIGIELSKI L, Jagannath V, Rossler W, Walitza S, et al
    Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings.
    Mol Psychiatry. 2020 Jan 6. pii: 10.1038/s41380-019-0601.
    PubMed     Text format     Abstract available


    December 2019
  6. GOBSHTIS N, Tfilin M, Fraifeld VE, Turgeman G, et al
    Transplantation of mesenchymal stem cells causes long-term alleviation of schizophrenia-like behaviour coupled with increased neurogenesis.
    Mol Psychiatry. 2019 Dec 11. pii: 10.1038/s41380-019-0623.
    PubMed     Text format     Abstract available


  7. GREENING DW, Notaras M, Chen M, Xu R, et al
    Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome.
    Mol Psychiatry. 2019 Dec 10. pii: 10.1038/s41380-019-0617.
    PubMed     Text format     Abstract available


  8. BORGAN F, O'Daly O, Veronese M, Reis Marques T, et al
    The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study.
    Mol Psychiatry. 2019 Dec 4. pii: 10.1038/s41380-019-0619.
    PubMed     Text format     Abstract available


    November 2019
  9. KOWALEC K, Lu Y, Sariaslan A, Song J, et al
    Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study.
    Mol Psychiatry. 2019 Nov 12. pii: 10.1038/s41380-019-0575.
    PubMed     Text format     Abstract available


  10. GORDON A, Forsingdal A, Klewe IV, Nielsen J, et al
    Transcriptomic networks implicate neuronal energetic abnormalities in three mouse models harboring autism and schizophrenia-associated mutations.
    Mol Psychiatry. 2019 Nov 8. pii: 10.1038/s41380-019-0576.
    PubMed     Text format     Abstract available


  11. D'AMBROSIO E, Jauhar S, Kim S, Veronese M, et al
    The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal (18)F-DOPA PET and voxel-based morphometry study.
    Mol Psychiatry. 2019 Nov 5. pii: 10.1038/s41380-019-0570.
    PubMed     Text format     Abstract available


    October 2019
  12. REAY WR, Cairns MJ
    The role of the retinoids in schizophrenia: genomic and clinical perspectives.
    Mol Psychiatry. 2019 Oct 30. pii: 10.1038/s41380-019-0566.
    PubMed     Text format     Abstract available


  13. ZHANG X, Yang M, Du X, Liao W, et al
    Correction: Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.
    Mol Psychiatry. 2019 Oct 22. pii: 10.1038/s41380-019-0552.
    PubMed     Text format     Abstract available


  14. BIGDELI TB, Genovese G, Georgakopoulos P, Meyers JL, et al
    Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry.
    Mol Psychiatry. 2019 Oct 7. pii: 10.1038/s41380-019-0517.
    PubMed     Text format     Abstract available


  15. KIM P, Scott MR, Meador-Woodruff JH
    Dysregulation of the unfolded protein response (UPR) in the dorsolateral prefrontal cortex in elderly patients with schizophrenia.
    Mol Psychiatry. 2019 Oct 2. pii: 10.1038/s41380-019-0537.
    PubMed     Text format     Abstract available


    September 2019
  16. CETIN-KARAYUMAK S, Di Biase MA, Chunga N, Reid B, et al
    White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study.
    Mol Psychiatry. 2019 Sep 11. pii: 10.1038/s41380-019-0509.
    PubMed     Text format     Abstract available


  17. HESS JL, Tylee DS, Mattheisen M, Borglum AD, et al
    A polygenic resilience score moderates the genetic risk for schizophrenia.
    Mol Psychiatry. 2019 Sep 6. pii: 10.1038/s41380-019-0463.
    PubMed     Text format     Abstract available


    August 2019
  18. MCCUTCHEON RA, Pillinger T, Mizuno Y, Montgomery A, et al
    The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis.
    Mol Psychiatry. 2019 Aug 30. pii: 10.1038/s41380-019-0502.
    PubMed     Text format     Abstract available


  19. TIAN X, Richard A, El-Saadi MW, Bhandari A, et al
    Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model.
    Mol Psychiatry. 2019 Aug 23. pii: 10.1038/s41380-019-0492.
    PubMed     Text format     Abstract available


  20. WOO JJ, Pouget JG, Zai CC, Kennedy JL, et al
    The complement system in schizophrenia: where are we now and what's next?
    Mol Psychiatry. 2019 Aug 22. pii: 10.1038/s41380-019-0479.
    PubMed     Text format     Abstract available


  21. ZHANG X, Yang M, Du X, Liao W, et al
    Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.
    Mol Psychiatry. 2019 Aug 13. pii: 10.1038/s41380-019-0478.
    PubMed     Text format     Abstract available


  22. ZHU F, Guo R, Wang W, Ju Y, et al
    Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice.
    Mol Psychiatry. 2019 Aug 7. pii: 10.1038/s41380-019-0475.
    PubMed     Text format     Abstract available


    July 2019
  23. NI P, Noh H, Park GH, Shao Z, et al
    Correction: iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function.
    Mol Psychiatry. 2019 Jul 31. pii: 10.1038/s41380-019-0467.
    PubMed     Text format     Abstract available


  24. SMELAND OB, Bahrami S, Frei O, Shadrin A, et al
    Correction: Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Mol Psychiatry. 2019 Jul 15. pii: 10.1038/s41380-019-0456.
    PubMed     Text format     Abstract available


    June 2019
  25. PURVES-TYSON TD, Weber-Stadlbauer U, Richetto J, Rothmond DA, et al
    Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation.
    Mol Psychiatry. 2019 Jun 5. pii: 10.1038/s41380-019-0434.
    PubMed     Text format     Abstract available


  26. SONE D, Beheshti I, Maikusa N, Ota M, et al
    Neuroimaging-based brain-age prediction in diverse forms of epilepsy: a signature of psychosis and beyond.
    Mol Psychiatry. 2019 Jun 3. pii: 10.1038/s41380-019-0446.
    PubMed     Text format     Abstract available


    May 2019
  27. ROSATO M, Stringer S, Gebuis T, Paliukhovich I, et al
    Combined cellomics and proteomics analysis reveals shared neuronal morphology and molecular pathway phenotypes for multiple schizophrenia risk genes.
    Mol Psychiatry. 2019 May 29. pii: 10.1038/s41380-019-0436.
    PubMed     Text format     Abstract available


  28. LESH TA, Maddock RJ, Howell A, Wang H, et al
    Extracellular free water and glutathione in first-episode psychosis-a multimodal investigation of an inflammatory model for psychosis.
    Mol Psychiatry. 2019 May 28. pii: 10.1038/s41380-019-0428.
    PubMed     Text format     Abstract available


  29. DIACONESCU AO, Hauke DJ, Borgwardt S
    Models of persecutory delusions: a mechanistic insight into the early stages of psychosis.
    Mol Psychiatry. 2019 May 10. pii: 10.1038/s41380-019-0427.
    PubMed     Text format     Abstract available


    April 2019
  30. NI P, Noh H, Park GH, Shao Z, et al
    iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function.
    Mol Psychiatry. 2019 Apr 24. pii: 10.1038/s41380-019-0423.
    PubMed     Text format     Abstract available


  31. RUTKOWSKI TP, Purcell RH, Pollak RM, Grewenow SM, et al
    Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion.
    Mol Psychiatry. 2019 Apr 11. pii: 10.1038/s41380-019-0413.
    PubMed     Text format     Abstract available


  32. KINDLER J, Lim CK, Weickert CS, Boerrigter D, et al
    Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia.
    Mol Psychiatry. 2019 Apr 3. pii: 10.1038/s41380-019-0401.
    PubMed     Text format     Abstract available


    March 2019
  33. DWIR D, Giangreco B, Xin L, Tenenbaum L, et al
    MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.
    Mol Psychiatry. 2019 Mar 25. pii: 10.1038/s41380-019-0393.
    PubMed     Text format     Abstract available


  34. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2019 Mar 12. pii: 10.1038/s41380-019-0373.
    PubMed     Text format     Abstract available


  35. ORLOVSKA-WAAST S, Kohler-Forsberg O, Brix SW, Nordentoft M, et al
    Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Mol Psychiatry. 2019 Mar 12. pii: 10.1038/s41380-019-0381.
    PubMed     Text format     Abstract available


  36. LEGGE SE, Pardinas AF, Helthuis M, Jansen JA, et al
    A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia.
    Mol Psychiatry. 2019;24:328-337.
    PubMed     Text format     Abstract available


  37. HORWITZ T, Lam K, Chen Y, Xia Y, et al
    A decade in psychiatric GWAS research.
    Mol Psychiatry. 2019;24:378-389.
    PubMed     Text format     Abstract available


    February 2019
  38. COLIZZI M, Weltens N, McGuire P, Lythgoe D, et al
    Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.
    Mol Psychiatry. 2019 Feb 15. pii: 10.1038/s41380-019-0374.
    PubMed     Text format     Abstract available


  39. ROALF DR, de la Garza AG, Rosen A, Calkins ME, et al
    Alterations in white matter microstructure in individuals at persistent risk for psychosis.
    Mol Psychiatry. 2019 Feb 5. pii: 10.1038/s41380-019-0360.
    PubMed     Text format     Abstract available


    January 2019
  40. HADAR R, Winter R, Edemann-Callesen H, Wieske F, et al
    Prevention of schizophrenia deficits via non-invasive adolescent frontal cortex stimulation in rats.
    Mol Psychiatry. 2019 Jan 28. pii: 10.1038/s41380-019-0356.
    PubMed     Text format     Abstract available


  41. SCOTT MR, Meador-Woodruff JH
    Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects.
    Mol Psychiatry. 2019 Jan 25. pii: 10.1038/s41380-019-0359.
    PubMed     Text format     Abstract available


  42. WARLAND A, Kendall KM, Rees E, Kirov G, et al
    Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank.
    Mol Psychiatry. 2019 Jan 24. pii: 10.1038/s41380-019-0355.
    PubMed     Text format     Abstract available


  43. MA L, Semick SA, Chen Q, Li C, et al
    Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19).
    Mol Psychiatry. 2019 Jan 11. pii: 10.1038/s41380-018-0293.
    PubMed     Text format     Abstract available


  44. AMARE AT, Vaez A, Hsu YH, Direk N, et al
    Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.
    Mol Psychiatry. 2019 Jan 9. pii: 10.1038/s41380-018-0336.
    PubMed     Text format     Abstract available


  45. ESCOTT-PRICE V, Bracher-Smith M, Menzies G, Walters J, et al
    Genetic liability to schizophrenia is negatively associated with educational attainment in UK Biobank.
    Mol Psychiatry. 2019 Jan 4. pii: 10.1038/s41380-018-0328.
    PubMed     Text format    


  46. SMELAND OB, Bahrami S, Frei O, Shadrin A, et al
    Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Mol Psychiatry. 2019 Jan 4. pii: 10.1038/s41380-018-0332.
    PubMed     Text format     Abstract available


    December 2018
  47. BERGMAN O, Karry R, Milhem J, Ben-Shachar D, et al
    NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.
    Mol Psychiatry. 2018 Dec 10. pii: 10.1038/s41380-018-0309.
    PubMed     Text format     Abstract available


  48. REAY WR, Atkins JR, Quide Y, Carr VJ, et al
    Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtype.
    Mol Psychiatry. 2018 Dec 7. pii: 10.1038/s41380-018-0305.
    PubMed     Text format     Abstract available


    November 2018
  49. RADULESCU E, Jaffe AE, Straub RE, Chen Q, et al
    Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain.
    Mol Psychiatry. 2018 Nov 26. pii: 10.1038/s41380-018-0304.
    PubMed     Text format     Abstract available


  50. COLLIN G, Seidman LJ, Keshavan MS, Stone WS, et al
    Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program.
    Mol Psychiatry. 2018 Nov 8. pii: 10.1038/s41380-018-0288.
    PubMed     Text format     Abstract available


    October 2018
  51. PILLINGER T, D'Ambrosio E, McCutcheon R, Howes OD, et al
    Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
    Mol Psychiatry. 2018 Oct 18. pii: 10.1038/s41380-018-0275.
    PubMed     Text format     Abstract available


  52. DOUCET GE, Moser DA, Luber MJ, Leibu E, et al
    Baseline brain structural and functional predictors of clinical outcome in the early course of schizophrenia.
    Mol Psychiatry. 2018 Oct 3. pii: 10.1038/s41380-018-0269.
    PubMed     Text format     Abstract available


    September 2018
  53. GUO JY, Ragland JD, Carter CS
    Memory and cognition in schizophrenia.
    Mol Psychiatry. 2018 Sep 21. pii: 10.1038/s41380-018-0231.
    PubMed     Text format     Abstract available


  54. WANG HY, MacDonald ML, Borgmann-Winter KE, Banerjee A, et al
    mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia.
    Mol Psychiatry. 2018 Sep 13. pii: 10.1038/s41380-018-0234.
    PubMed     Text format     Abstract available


  55. CAI HQ, Catts VS, Webster MJ, Galletly C, et al
    Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation.
    Mol Psychiatry. 2018 Sep 13. pii: 10.1038/s41380-018-0235.
    PubMed     Text format     Abstract available


    August 2018
  56. ORLOVSKA-WAAST S, Kohler-Forsberg O, Brix SW, Nordentoft M, et al
    Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Mol Psychiatry. 2018 Aug 16. pii: 10.1038/s41380-018-0220.
    PubMed     Text format     Abstract available


    July 2018
  57. SEGEV A, Yanagi M, Scott D, Southcott SA, et al
    Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors.
    Mol Psychiatry. 2018 Jul 23. pii: 10.1038/s41380-018-0124.
    PubMed     Text format     Abstract available


    June 2018
  58. KUMAR J, Liddle EB, Fernandes CC, Palaniyappan L, et al
    Glutathione and glutamate in schizophrenia: a 7T MRS study.
    Mol Psychiatry. 2018 Jun 22. pii: 10.1038/s41380-018-0104.
    PubMed     Text format     Abstract available


  59. CAO B, Cho RY, Chen D, Xiu M, et al
    Treatment response prediction and individualized identification of first-episode drug-naive schizophrenia using brain functional connectivity.
    Mol Psychiatry. 2018 Jun 19. pii: 10.1038/s41380-018-0106.
    PubMed     Text format     Abstract available


  60. SUN D, Ching CRK, Lin A, Forsyth JK, et al
    Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
    Mol Psychiatry. 2018 Jun 13. pii: 10.1038/s41380-018-0078.
    PubMed     Text format     Abstract available


  61. CHAUMETTE B, Ferrafiat V, Ambalavanan A, Goldenberg A, et al
    Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.
    Mol Psychiatry. 2018 Jun 12. pii: 10.1038/s41380-018-0103.
    PubMed     Text format     Abstract available


  62. EGERTON A, Broberg BV, Van Haren N, Merritt K, et al
    Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE).
    Mol Psychiatry. 2018 Jun 7. pii: 10.1038/s41380-018-0082.
    PubMed     Text format     Abstract available


    May 2018
  63. PILLINGER T, D'Ambrosio E, McCutcheon R, D Howes O, et al
    Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
    Mol Psychiatry. 2018 May 9. pii: 10.1038/s41380-018-0058.
    PubMed     Text format     Abstract available


  64. HAUBERG ME, Fullard JF, Zhu L, Cohain AT, et al
    Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
    Mol Psychiatry. 2018 May 8. pii: 10.1038/s41380-018-0059.
    PubMed     Text format     Abstract available


  65. YALLA K, Elliott C, Day JP, Findlay J, et al
    FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system.
    Mol Psychiatry. 2018;23:1278-1286.
    PubMed     Text format     Abstract available


  66. DEVANNA P, Chen XS, Ho J, Gajewski D, et al
    Next-gen sequencing identifies non-coding variation disrupting miRNA-binding sites in neurological disorders.
    Mol Psychiatry. 2018;23:1375-1384.
    PubMed     Text format     Abstract available


  67. ORHAN F, Fatouros-Bergman H, Goiny M, Malmqvist A, et al
    CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
    Mol Psychiatry. 2018;23:1244-1250.
    PubMed     Text format     Abstract available


  68. VAUCHER J, Keating BJ, Lasserre AM, Gan W, et al
    Cannabis use and risk of schizophrenia: a Mendelian randomization study.
    Mol Psychiatry. 2018;23:1287-1292.
    PubMed     Text format     Abstract available


    April 2018
  69. JAUHAR S, Veronese M, Nour MM, Rogdaki M, et al
    Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study.
    Mol Psychiatry. 2018 Apr 20. pii: 10.1038/s41380-018-0042.
    PubMed     Text format     Abstract available


  70. BOKU S, Izumi T, Abe S, Takahashi T, et al
    Copy number elevation of 22q11.2 genes arrests the developmental maturation of working memory capacity and adult hippocampal neurogenesis.
    Mol Psychiatry. 2018;23:985-992.
    PubMed     Text format     Abstract available


    March 2018
  71. CHOUINARD VA, Henderson DC, Dalla Man C, Valeri L, et al
    Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis.
    Mol Psychiatry. 2018 Mar 9. pii: 10.1038/s41380-018-0045.
    PubMed     Text format     Abstract available


  72. OSIMO EF, Beck K, Reis Marques T, Howes OD, et al
    Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Mol Psychiatry. 2018 Mar 6. pii: 10.1038/s41380-018-0041.
    PubMed     Text format     Abstract available


  73. SULLIVAN CR, Koene RH, Hasselfeld K, O'Donovan SM, et al
    Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.
    Mol Psychiatry. 2018 Mar 1. pii: 10.1038/s41380-018-0035.
    PubMed     Text format     Abstract available


    February 2018
  74. KIM DD, Barr AM, Honer WG, Procyshyn RM, et al
    Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia.
    Mol Psychiatry. 2018 Feb 8. pii: 10.1038/s41380-018-0022.
    PubMed     Text format    


  75. ZILHAO NR, Abdellaoui A, Smit DJA, Cath DC, et al
    Polygenic prediction of obsessive compulsive symptoms.
    Mol Psychiatry. 2018;23:168-169.
    PubMed     Text format    


  76. PAGE SC, Hamersky GR, Gallo RA, Rannals MD, et al
    The schizophrenia- and autism-associated gene, transcription factor 4 regulates the columnar distribution of layer 2/3 prefrontal pyramidal neurons in an activity-dependent manner.
    Mol Psychiatry. 2018;23:304-315.
    PubMed     Text format     Abstract available


  77. ROFFMAN JL, Petruzzi LJ, Tanner AS, Brown HE, et al
    Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.
    Mol Psychiatry. 2018;23:316-322.
    PubMed     Text format     Abstract available


  78. NOTTER T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, et al
    Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
    Mol Psychiatry. 2018;23:323-334.
    PubMed     Text format     Abstract available


  79. ST POURCAIN B, Robinson EB, Anttila V, Sullivan BB, et al
    ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties.
    Mol Psychiatry. 2018;23:263-270.
    PubMed     Text format     Abstract available


  80. EHRENREICH H, Mitjans M, Van der Auwera S, Centeno TP, et al
    OTTO: a new strategy to extract mental disease-relevant combinations of GWAS hits from individuals.
    Mol Psychiatry. 2018;23:476-486.
    PubMed     Text format     Abstract available


  81. SCARR E, Udawela M, Thomas EA, Dean B, et al
    Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.
    Mol Psychiatry. 2018;23:295-303.
    PubMed     Text format     Abstract available


  82. XU J, Hartley BJ, Kurup P, Phillips A, et al
    Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.
    Mol Psychiatry. 2018;23:271-281.
    PubMed     Text format     Abstract available


    January 2018
  83. LIEBERMAN JA, Girgis RR, Brucato G, Moore H, et al
    Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.
    Mol Psychiatry. 2018 Jan 9. pii: mp2017249. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  84. DE VRIJ FM, Bouwkamp CG, Gunhanlar N, Shpak G, et al
    Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia.
    Mol Psychiatry. 2018 Jan 4. pii: 10.1038/s41380-017-0004.
    PubMed     Text format     Abstract available


  85. MITCHELL AC, Javidfar B, Pothula V, Ibi D, et al
    MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
    Mol Psychiatry. 2018;23:123-132.
    PubMed     Text format     Abstract available


    November 2017
  86. STEULLET P, Cabungcal JH, Bukhari SA, Ardelt MI, et al
    The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.
    Mol Psychiatry. 2017 Nov 28. pii: mp2017230. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  87. CHENG CM, Chang WH, Chen MH, Tsai CF, et al
    Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  88. ENWRIGHT III JF, Huo Z, Arion D, Corradi JP, et al
    Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  89. KENDLER KS
    The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900.
    Mol Psychiatry. 2017;22:1539-1553.
    PubMed     Text format     Abstract available


    October 2017
  90. KELLY S, Jahanshad N, Zalesky A, Kochunov P, et al
    Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.
    Mol Psychiatry. 2017 Oct 17. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  91. GREENE C, Kealy J, Humphries MM, Gong Y, et al
    Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.
    Mol Psychiatry. 2017 Oct 10. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  92. LEGGE SE, Hamshere ML, Ripke S, Pardinas AF, et al
    Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.
    Mol Psychiatry. 2017;22:1502-1508.
    PubMed     Text format     Abstract available


    September 2017
  93. ZHOU Y, Dong F, Lanz TA, Reinhart V, et al
    Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment.
    Mol Psychiatry. 2017 Sep 19. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  94. SOLIMAN MA, Aboharb F, Zeltner N, Studer L, et al
    Pluripotent stem cells in neuropsychiatric disorders.
    Mol Psychiatry. 2017;22:1241-1249.
    PubMed     Text format     Abstract available


    August 2017
  95. ALACHKAR A, Wang L, Yoshimura R, Hamzeh AR, et al
    Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits.
    Mol Psychiatry. 2017 Aug 15. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  96. GUR RE, Bassett AS, McDonald-McGinn DM, Bearden CE, et al
    A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  97. NIMGAONKAR VL, Prasad KM, Chowdari KV, Severance EG, et al
    The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    July 2017
  98. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 Jul 25. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  99. BENAMER N, Marti F, Lujan R, Hepp R, et al
    GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.
    Mol Psychiatry. 2017 Jul 11. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  100. RAO AR, Yourshaw M, Christensen B, Nelson SF, et al
    Rare deleterious mutations are associated with disease in bipolar disorder families.
    Mol Psychiatry. 2017;22:1009-1014.
    PubMed     Text format     Abstract available


    June 2017
  101. TENG S, Thomson PA, McCarthy S, Kramer M, et al
    Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia.
    Mol Psychiatry. 2017 Jun 20. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    May 2017
  102. KIM Y, Giusti-Rodriguez P, Crowley JJ, Bryois J, et al
    Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects.
    Mol Psychiatry. 2017 May 30. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  103. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  104. MOBERGET T, Doan NT, Alnaes D, Kaufmann T, et al
    Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  105. BIRNBAUM R, Jaffe AE, Chen Q, Shin JH, et al
    Investigating the neuroimmunogenic architecture of schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  106. TAO R, Davis KN, Li C, Shin JH, et al
    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  107. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2017 May 2. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    April 2017
  108. DUNCAN LE, Ratanatharathorn A, Aiello AE, Almli LM, et al
    Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
    Mol Psychiatry. 2017 Apr 25. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  109. HADAR R, Bikovski L, Soto-Montenegro ML, Schimke J, et al
    Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.
    Mol Psychiatry. 2017 Apr 4. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    March 2017
  110. NOTTER T, Meyer U
    Microglia and schizophrenia: where next?
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format    


  111. PARKER KL, Kim YC, Kelley RM, Nessler AJ, et al
    Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  112. LYALL AE, Pasternak O, Robinson DG, Newell D, et al
    Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  113. DEVOR A, Andreassen OA, Wang Y, Maki-Marttunen T, et al
    Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  114. STEULLET P, Cabungcal JH, Coyle J, Didriksen M, et al
    Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.
    Mol Psychiatry. 2017 Mar 21. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  115. WESSELING H, Xu B, Want EJ, Holmes E, et al
    System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterations.
    Mol Psychiatry. 2017;22:384-395.
    PubMed     Text format     Abstract available


    January 2017
  116. WEBER-STADLBAUER U, Richetto J, Labouesse MA, Bohacek J, et al
    Transgenerational transmission and modification of pathological traits induced by prenatal immune activation.
    Mol Psychiatry. 2017;22:102-112.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: